Description

This ELISA (enzyme-linked immunosorbent assay) kit is intended for the quantitative determination of human calprotectin (neutrophil cytoplasmic protein A100A8/A9) levels in stool samples. This test is useful for detecting inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn’s disease.

For in-vitro diagnostic use.

Background

Quantitative determination of fecal calprotectin is an indication of the severity of bowel inflammation. High levels of calprotectin in stool are associated with an increased risk of relapse in patients with inflammatory bowel disease (IBD). Low stool calprotectin levels correlate well with a low risk for intestinal allograft injection. This assay uses specific monoclonal antibodies to ensure that only calprotectin is detected.